EU 'Forever Chemicals' Ban and Global Health Shake-ups
The EU plans to ban PFAS in consumer products due to environmental concerns. The U.S. withdraws from WHO, impacting global health funding. France's bird flu response alters poultry trade. Swiss firm BioVersys eyes IPO. Tanzania confirms Marburg outbreak, while England detects a new mpox variant.
The European Union is poised to prohibit the use of PFAS chemicals in consumer products, despite allowing certain industrial exemptions. Known as 'forever chemicals', they persist in nature, raising alarm over their accumulation in the environment and human bodies.
In a significant move, the United States will exit the World Health Organization, a decision announced by President Trump citing WHO's suspected political influence and financial imbalances. This withdrawal could substantially affect global health emergency responses and funding.
In other health-related updates, the U.S. and Canada have relaxed bans on some French poultry, the Basel-based BioVersys plans a public listing, and Tanzania reports a Marburg virus outbreak. Meanwhile, a new mpox variant has been identified in England, though risks remain low according to health authorities.
(With inputs from agencies.)
ALSO READ
Health Headlines: From ALS Drug Setbacks to Bird Flu Misfortunes
Low Risk of H5N1 Bird Flu in the U.S.: WHO Assurance
Global Health Highlights: Tackling Bird Flu, Gas Stove Controversy, and Advancements in Cancer Treatment
Global Health Alerts: From Executive Orders to Bird Flu Concerns
US Rebuilds Bird Flu Vaccine Stockpile Amid Outbreak